Genetic/Epigenetic Alteration and Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Transforming the Immune Microenvironment with Molecular-Targeted Agents
Combination approaches that target both the tumor and immune system hold promise for improving the outcomes of patients with iCCA. Further research and clinical trials are needed to validate these approaches and optimize the treatment strategies for iCCA.
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, Emily R. Bramel, Philipp K. Haber, Elliot Merritt, Alexander Rialdi, Nesteene J. Param, Miho Maeda, Katherine E. Lindblad, James K. Carter, Marina Bárcena‐Varela, Vincenzo Mazzaferro, Myron Schwartz, Silvia Affò, Robert F. Schwabe, Augusto Villanueva, Ernesto Guccione, Scott L. Friedman, Amaia Lujambio, Anna S. Tocheva, Josep M. Llovet, Swan N. Thung, Alexander M. Tsankov, Daniela Sia
Colm J. O’Rourke, Massimiliano Salati, Colin Rae, Guido Carpino, Holly Leslie, Antonio Pea, Maria Giuseppina Prete, Luca Reggiani Bonetti, Francesco Amato, Robert Montal, Rosanna Upstill‐Goddard, Colin Nixon, Paula Sanchon-Sanchez, Paolo Kunderfranco, Daniela Sia, Eugenio Gaudio, Diletta Overi, Stefano Cascinu, Dan Høgdall, S. Pugh, Enric Domingo, John Primrose, John Bridgewater,
Discussion(0)
No comments yet. Be the first to comment.